Elisa Schmoeckel

1.8k total citations · 1 hit paper
92 papers, 1.2k citations indexed

About

Elisa Schmoeckel is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Elisa Schmoeckel has authored 92 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 36 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Elisa Schmoeckel's work include Reproductive System and Pregnancy (16 papers), Ovarian cancer diagnosis and treatment (16 papers) and Galectins and Cancer Biology (13 papers). Elisa Schmoeckel is often cited by papers focused on Reproductive System and Pregnancy (16 papers), Ovarian cancer diagnosis and treatment (16 papers) and Galectins and Cancer Biology (13 papers). Elisa Schmoeckel collaborates with scholars based in Germany, Switzerland and United States. Elisa Schmoeckel's co-authors include Udo Jeschke, Doris Mayr, Sven� Mahner, Christina Kühn, Thomas Kolben, Anne Kathrin Höhn, Lars‐Christian Horn, Grit Gesine Ruth Hiller, Christine Brambs and Bastian Czogalla and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Elisa Schmoeckel

92 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 WHO Classification of Female Genital Tumors

2021 160 citations Anne Kathrin Höhn, Grit Gesine Ruth Hiller et al. profile →

Peers

Elisa Schmoeckel

IMMUN

ONCOL

Takahide Arimoto Japan

Fen Ning China

Zhaogang Dong China

Zheng Feng China

Xi Xia China

Mike R. Wilson United States

Xianrong Zhou China

H.G. Meerpohl Germany

Hideki Ishihara Japan

Nina Radosevic‐Robin France

Takahide Arimoto Japan

Elisa Schmoeckel

349 ×0.9

274 ×0.7

IMMUN

274 ×0.9

ONCOL

217 ×1.0

252 ×1.2

Citations per year, relative to Elisa Schmoeckel Elisa Schmoeckel (= 1×) peers Takahide Arimoto

Countries citing papers authored by Elisa Schmoeckel

Since Specialization

Citations

This map shows the geographic impact of Elisa Schmoeckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Schmoeckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Schmoeckel more than expected).

Fields of papers citing papers by Elisa Schmoeckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Schmoeckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Schmoeckel. The network helps show where Elisa Schmoeckel may publish in the future.

Co-authorship network of co-authors of Elisa Schmoeckel

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Schmoeckel. A scholar is included among the top collaborators of Elisa Schmoeckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Schmoeckel. Elisa Schmoeckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haas, Anette, Mohid S. Khan, Azar Kazemi, et al.. (2025). An equivalency and efficiency study for one year digital pathology for clinical routine diagnostics in an accredited tertiary academic center. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(1). 3–12. 3 indexed citations

Kolben, Thomas, Carolin Perleberg, Sarah Meister, et al.. (2024). CCL22 as an independent prognostic factor in endometrial cancer patients. Translational Oncology. 50. 102116–102116. 1 indexed citations

Vilsmaier, Theresa�, et al.. (2023). POSTER 17The cytokines IL-1b and IL-18 are upregulated in the placenta of recurrent miscarriage patients. Journal of Reproductive Immunology. 158. 103600–103600. 1 indexed citations

Jueckstock, J, Aurelia Vattai, Helene Hildegard Heidegger, et al.. (2023). MTA1 as negative prognostic marker in vulvar carcinoma. Journal of Cancer Research and Clinical Oncology. 149(9). 6191–6201. 1 indexed citations

Schmoeckel, Elisa, Sven Mahner, Doris Mayr, et al.. (2023). RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro. Frontiers in Oncology. 13. 1110939–1110939. 8 indexed citations

Meister, Sarah, Susanne Beyer, Carolin Perleberg, et al.. (2022). Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2. International Journal of Molecular Sciences. 23(3). 1880–1880. 12 indexed citations

Kolben, Thomas, Carolin Perleberg, David Anz, et al.. (2022). Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells. Cellular Oncology. 45(6). 1171–1185. 11 indexed citations

Vattai, Aurelia, Christina Kühn, Achim Wöckel, et al.. (2022). The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients. Journal of Reproductive Immunology. 153. 103663–103663. 8 indexed citations

Vattai, Aurelia, Theresa� Vilsmaier, Alexander Steger, et al.. (2022). Prostaglandin E2 receptor EP1 expression in vulvar cancer. Journal of Cancer Research and Clinical Oncology. 149(8). 5369–5376. 3 indexed citations

10.

Vattai, Aurelia, Elisa Schmoeckel, Till Kaltofen, et al.. (2021). Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer. International Journal of Molecular Sciences. 22(16). 8479–8479. 7 indexed citations

11.

Kaltofen, Till, Doris Mayr, Elisa Schmoeckel, et al.. (2021). Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway. Biomedicines. 9(7). 706–706. 6 indexed citations

12.

Chen, Fangfang, Thomas Kolben, Sarah Meister, et al.. (2021). The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer. Archives of Gynecology and Obstetrics. 305(6). 1559–1572. 6 indexed citations

13.

Kolben, Thomas, Sven Mahner, Susanne Beyer, et al.. (2021). The role of E-Cadherin expression in primary site of breast cancer. Archives of Gynecology and Obstetrics. 305(4). 913–920. 11 indexed citations

14.

Mayr, Doris, Elisa Schmoeckel, Anne Kathrin Höhn, Grit Gesine Ruth Hiller, & Lars‐Christian Horn. (2021). Aktuelle WHO-Klassifikation des weiblichen Genitale. Der Pathologe. 42(3). 259–269. 8 indexed citations

15.

Vattai, Aurelia, Christina Kühn, Elisa Schmoeckel, et al.. (2020). Spliceosome protein EFTUD2 is upregulated in the trophoblast of spontaneous miscarriage and hydatidiform mole. Journal of Reproductive Immunology. 140. 103149–103149. 6 indexed citations

16.

Schmoeckel, Elisa, Christina Kühn, Thomas Blankenstein, et al.. (2020). Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation. Journal of Cancer Research and Clinical Oncology. 146(7). 1847–1855. 6 indexed citations

17.

Czogalla, Bastian, Doris Mayr, Elisa Schmoeckel, et al.. (2019). <p>Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology</p>. Cancer Management and Research. Volume 11. 7673–7684. 14 indexed citations

18.

Piseddu, Ignazio, Gabriela M. Wiedemann, Michael Lauseker, et al.. (2018). CCL1 is a major regulatory T cell attracting factor in human breast cancer. BMC Cancer. 18(1). 1278–1278. 58 indexed citations

19.

Kolben, Thomas, Udo Jeschke, Toralf Reimer, et al.. (2017). Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling. Journal of Cancer Research and Clinical Oncology. 144(2). 249–256. 14 indexed citations

20.

Schmoeckel, Elisa, Miriam Rottmann, Andrea Flesken‐Nikitin, et al.. (2017). LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions. Modern Pathology. 30(9). 1241–1250. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact